Dapagliflozin + Saxagliptin
Composition
This formulation contain combination of Dapagliflozin and Saxagliptin as active agents
Indications
the management of type 2 diabetes mellitus to improve glycemic control in adults
Side effects
urinary tract infections, genital mycotic infections, nasopharyngitis, headache, and hypoglycemia
Precautions
with caution in individuals with a history of urinary tract infections, volume depletion, or renal impairment
Contraindications
individuals with type 1 diabetes mellitus or diabetic ketoacidosis
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet